Trials / Available
AvailableNCT06362590
Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Seagen Inc. · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ladiratuzumab vedotin |
Timeline
- First posted
- 2024-04-12
- Last updated
- 2025-06-17
Source: ClinicalTrials.gov record NCT06362590. Inclusion in this directory is not an endorsement.